Diabetic nephropathy (DN) is one of the microvascular complications of diabetes affecting 30-40% of diabetic patients and represents the leading cause of end-stage kidney disease (ESKD). Treatment strategies are rare. Given the significant healthcare impact and high economic burden of DN, there is an urgent need for adequate and targeted management of the disease for early diagnosis and prevention of progression to ESKD. Articles of this Research Topic provide a general overview of DN, highlight the importance of early detection of this disease, and suggest new diagnostic tools and treatment strategies.
Rando, M. M., Guthoff, M., Tiwari, V., Biscetti, F., Editorial: Diagnosis, prevention and treatment in diabetic nephropathy, <<FRONTIERS IN ENDOCRINOLOGY>>, 2022; 13 (13): N/A-N/A. [doi:10.3389/fendo.2022.1011665] [https://hdl.handle.net/10807/305658]
Editorial: Diagnosis, prevention and treatment in diabetic nephropathy
Rando, Maria Margherita;Biscetti, Federico
2022
Abstract
Diabetic nephropathy (DN) is one of the microvascular complications of diabetes affecting 30-40% of diabetic patients and represents the leading cause of end-stage kidney disease (ESKD). Treatment strategies are rare. Given the significant healthcare impact and high economic burden of DN, there is an urgent need for adequate and targeted management of the disease for early diagnosis and prevention of progression to ESKD. Articles of this Research Topic provide a general overview of DN, highlight the importance of early detection of this disease, and suggest new diagnostic tools and treatment strategies.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
